Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. - Wikidata - awgldk - TriplyDB

Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.

Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.

http://www.wikidata.org/entity/Q33675852

about

Adhesive Pili in UTI Pathogenesis and Drug Development Virulence and Fitness Determinants of Uropathogenic Escherichia coli Intracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract Symptoms High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.An Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli Infections Genomic and metabolic profiling of nonulosonic acids in Vibrionaceae reveal biochemical phenotypes of allelic divergence in Vibrio vulnificus The LysR-type transcriptional regulator QseD alters type three secretion in enterohemorrhagic Escherichia coli and motility in K-12 Escherichia coli.Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia.Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors.How to make it in the urinary tract: a tutorial by Escherichia coli Aberrant community architecture and attenuated persistence of uropathogenic Escherichia coli in the absence of individual IHF subunits.Pleiotropic roles of uvrY on biofilm formation, motility and virulence in uropathogenic Escherichia coli CFT073 Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.Phenotypic Heterogeneity in Expression of the K1 Polysaccharide Capsule of Uropathogenic Escherichia coli and Downregulation of the Capsule Genes during Growth in Urine Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo.The Biology of the Escherichia coli Extracellular Matrix Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.The efficacy of immediate versus delayed antibiotic administration on bacterial growth and biofilm production of selected strains of uropathogenic Escherichia coli and Pseudomonas aeruginosa.Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.AutA and AutR, Two Novel Global Transcriptional Regulators, Facilitate Avian Pathogenic Escherichia coli Infection.Molecular Characterization of the Vacuolating Autotransporter Toxin in Uropathogenic Escherichia coli.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Uropathogenic Escherichia coli-Associated Exotoxins Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis Recurrent urinary tract infections in healthy and nonpregnant women Lipopolysaccharide Domains Modulate Urovirulence.The Catabolite Repressor Protein-Cyclic AMP Complex Regulates csgD and Biofilm Formation in Uropathogenic Escherichia coli.Invasion of Host Cells and Tissues by Uropathogenic Bacteria.Amplifying renal immunity: the role of antimicrobial peptides in pyelonephritis.Bacterial Surfaces: Front Lines in Host-Pathogen Interaction.A histochemical approach to glycan diversity in the urothelium of pig urinary bladder.Discovery and characterization of de novo sialic acid biosynthesis in the phylum Fusobacterium.Zinc oxide nanoparticle reduced biofilm formation and antigen 43 expressions in uropathogenic Escherichiacoli.

P2860

Q26752944-963DC5D9-A0EE-4760-A0D1-6B26A5EF88CA Q26782598-373E9B49-615A-4AAD-B60B-35D9622B4CC1 Q26799248-BF4BDB3C-E66D-47A3-BFA4-19E13444CD7A Q28474866-2C1F6530-88E6-478F-A470-678FA81FF02A Q28540213-75C4CDF5-8E07-4D14-9263-7B34B025E0ED Q28829569-F73D81EF-884B-4A3E-A251-A4DFE2A3AD25 Q33601086-B8399003-5425-4188-9A31-D78419CC1211 Q33650044-86FCE09F-E41D-439B-ABC6-DA3DA0D47503 Q33949399-89DBE46C-7331-4CEA-8AA8-C81C9B424534 Q33962948-55C51398-32BB-40AD-AE17-473A615FE6FA Q34356627-D60AB93E-49F3-46EE-9F6B-AA27787062AF Q34415785-C21838A3-CAEF-4875-8B40-C543444FD318 Q34440629-DBC4E1EA-39FA-473D-A431-5D26D356089A Q34469467-FB33AA5F-3B50-4E69-A63D-1BB31049AA07 Q34577149-FCF1C87C-E543-44FD-97FB-FE33936756F7 Q34876396-2463850B-80DE-42D3-8C08-4C95318F04E4 Q35745575-C87C74BF-D7CD-4D0E-9DF8-DEF11CDE0257 Q35833811-D2E0CEEF-040E-4919-952E-71CEC9C80A98 Q35865857-45800825-4BBA-4A54-AC3C-90FF66C83AE8 Q36032748-CFF3F813-B6DF-4CFE-BDDC-FE3587627984 Q36211104-F70AB579-BF7E-4CAF-BE6D-91B82FA2449C Q36396917-69D624E5-529B-48CE-BB75-9F35E9E3B0F5 Q36575733-2E0CABBD-7F15-4728-BC24-3B5F22D36B5B Q36705848-112B849A-AD42-4B8C-8372-20EEC475916E Q36835570-37ED111D-0B69-494A-AFC9-BB20787F7031 Q36878446-AAF6833E-978D-4562-B44F-5D2C629ACB21 Q36910650-1BC71B0D-EE19-4171-A105-8478E1617D92 Q36933039-F89AE7D4-425F-4194-A542-BF9EF6D7BDCF Q36951570-FE1D6F8F-E322-41BA-AF4A-5168619AFCD8 Q37035981-2E8EABC4-21F8-431E-B82C-79EDC2C25CF4 Q37123051-23076A24-41C2-46D5-9D75-E37D49FEE83D Q37152657-C72D822F-4242-4061-910E-7D830B92840B Q37345901-B334E0B8-5586-46AF-918B-87D5D8B9F2BD Q37425418-BFF94392-0CFE-47E3-9F99-B6A10EB75D0C Q37593454-EF57CAD9-69F9-4E09-B1BC-159DCE118C9C Q38543398-8FE93952-3AD0-40AA-915A-83FD2C1B7BEB Q38837720-7A83A1FE-F819-4076-93DE-5F1F907231E8 Q39228070-D8950BDB-FC98-490A-A28B-C329979924EB Q39404763-228D506C-F50E-4B55-9583-27D9AB091C2A Q40095162-90DC5025-846E-4495-A46E-058534FC0AC3

P2860

Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.

http://www.wikidata.org/entity/Q33675852

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Polysaccharide capsule and sia ...... l communities during cystitis.

@ast

Polysaccharide capsule and sia ...... l communities during cystitis.

@en

type

label

Polysaccharide capsule and sia ...... l communities during cystitis.

@ast

Polysaccharide capsule and sia ...... l communities during cystitis.

@en

prefLabel

Polysaccharide capsule and sia ...... l communities during cystitis.

@ast

Polysaccharide capsule and sia ...... l communities during cystitis.

@en

P1433

Q33675852-A20EE8F3-FB88-4A71-930B-7E9F97699AAB

P1476

Q33675852-50F94E72-FDA9-49E4-B5DD-B78BD6B76279

P2093

Q33675852-0CA7E2F2-58FC-42D3-8015-875ABC47EA10

Q33675852-43077DF7-E27F-4DAF-B9E5-6204A12482B9

Q33675852-730DF122-7C34-4EFA-A09D-16042DFAE4FB

Q33675852-7ADF08E8-A9E5-447A-B385-BE4E474F63A8

Q33675852-EBDAF14C-5588-4F72-B704-A0B5D7EF311C

P2860

Q33675852-00091E63-56C6-4245-A87B-F8795C3375CC

Q33675852-0089F06E-BDF2-4FF7-A9AC-95E8D7BB83B6

Q33675852-061052A2-FD3C-4103-987A-D838DE7E3B31

Q33675852-0AEE0F5C-B17A-4693-9C34-FA5B1D45FD2D

Q33675852-12A55D2A-918C-4C5C-B312-1ECF5D222CFD

Q33675852-13D06DB4-EC94-49BE-ACD4-8E4DEAC97964

Q33675852-13FBCE0F-D0FC-44B6-9477-C2F95A92D292

Q33675852-1709CFD1-0E4E-40C9-A61F-1229DF116614

Q33675852-18C2885E-5DFC-471D-88F2-A282D9CADFFB

Q33675852-18F9ED2F-47CF-48B6-A7BD-37854FF6DBAF

P304

Q33675852-5DF4F9FA-0972-4200-85B0-979AF145E175

P31

Q33675852-3286A14B-9626-435C-B291-B425644EEEBA

P356

Q33675852-00AE2F1A-0E77-4DC1-B34E-0028FCB343A4

P407

Q33675852-5B258C3E-D232-49C9-B822-D072F20088B3

P433

Q33675852-A5541349-E82A-41D7-B133-FF89BD277BD0

P478

Q33675852-CCCB1DDA-9FCF-453B-93EC-C1A34A561197

P577

Q33675852-47E080A1-14DE-4475-AC8C-2CB2AC780B1E

P5875

Q33675852-F1DF5BD4-8AC1-4A0E-A5F6-C35D363B550F

P698

Q33675852-3562814B-C1DA-4B04-8F08-132834684DAC

P921

Q33675852-18ACC302-3B3A-4950-ACE3-1004B38028A0

Q33675852-38A9B6B2-404D-4BC2-8680-74FB4493F2B1

P932

Q33675852-84AC1CF7-D1F5-401E-AE6B-9D232BDA8318

P356

P1433

Infection and Immunity

P1476

Polysaccharide capsule and sia ...... l communities during cystitis.

@en

P2093

Carlos C Goller

http://www.w3.org/2001/XMLSchema#string

Gregory G Anderson

http://www.w3.org/2001/XMLSchema#string

Patrick C Seed

http://www.w3.org/2001/XMLSchema#string

Scott J Hultgren

http://www.w3.org/2001/XMLSchema#string

Sheryl Justice

http://www.w3.org/2001/XMLSchema#string

P2860

Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection

Genetic and Physical Mapping of theLpsLocus: Identification of the Toll-4 Receptor as a Candidate Gene in the Critical Region

Filamentation by Escherichia coli subverts innate defenses during urinary tract infection

Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. coli

The complete genome sequence of Escherichia coli K-12

One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products

Contact-dependent inhibition of growth in Escherichia coli

Virulence factors in Escherichia coli urinary tract infection

Bacterial biofilms: from the natural environment to infectious diseases

Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant

P304

963-975

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00925-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41088191

http://www.w3.org/2001/XMLSchema#string

P698

20086090

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

2825929

http://www.w3.org/2001/XMLSchema#string